270 likes | 809 Views
ACD-CPR with an ITD: Teaching Concepts. Presenter Disclosure. Terry Provo, EMT-P, BA Director of Clinical Marketing Advanced Circulatory Systems ResQPOD ® ITD ResQPUMP ® ACD-CPR Device Currently under FDA review for approval ResQGARD ® ITD. How CPR circulates blood.
E N D
ACD-CPR with an ITD: Teaching Concepts
Presenter Disclosure Terry Provo, EMT-P, BA • Director of Clinical Marketing • Advanced Circulatory Systems • ResQPOD® ITD • ResQPUMP® ACD-CPR Device • Currently under FDA review for approval • ResQGARD® ITD
Compression Phase • Cardiac Pump Theory • Heart is squeezed between sternum & spine • Thoracic Pump Theory • Chest acts like a bellows • Compression creates a POSTIVE PRESSURE that causes: • Blood to leave the heart (CARDIAC OUTPUT) • Air to exit the lungs • ICP to increase
Chest Wall Recoil Phase • NEGATIVE PRESSURE (vacuum) develops drawing: • Blood back into heart (PRELOAD) • Air back into lungs • Coronary blood flow occurs • ICP is lowered
20 – 30% of normal blood flow to brain Conventional CPR Provides Only… 10 – 20% of normal blood flow to heart
Impedance Threshold Device (ITD) • Enhanced negative pressure is accomplished with an ITD • Prevents influx of air during chest wall recoil
Effect of ITD on Vacuum Greater vacuum (negative pressure) in the chest during chest wall recoil phase
Teaching Concept CPR with an ITD Conventional CPR Hole
#2: Vacuum Dependent Upon Chest Wall Recoil COMPLETEChest Wall Recoil INCOMPLETEChest Wall Recoil
ACD-CPR Device Active compression decompression CPR (ACD-CPR)actively re-expands the chest rather than relaying on it to recoil passively
ACD-CPR Optimizes Chest Wall Recoil Conventional CPR ACD-CPR
Synergistic Device Combination ITD = Activator “Plugs the leak in the system” ACD-CPR
Improved Blood Pressure mmHg P<0.05 for differences between S-CPR & S-CPR + ITD, and ACD-CPR & ResQCPR Pirrallo et al. Resuscitation 2005;(66):13-20 and Plaisance et al. Circulation 2000;(101):989-994.
Improved Long-Term Survival with Favorable Neurologic Recovery % 53% improvement (p=0.019) 49% improvement (p=0.03) Aufderheide et al. Lancet 2011;377(9762):301-311.
Thank you Terry Provo • Phone: 651-403-5608 • Email: tprovo@advancedcirculatory.com